---
title: "Citic Securities Sticks to Its Buy Rating for BeOne Medicines Ltd (6160)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286337391.md"
description: "Citic Securities has reaffirmed its Buy rating for BeOne Medicines Ltd (6160) as of May 12, setting a price target of HK$234.00, while the shares closed at HK$189.90. The analyst consensus for the stock is Strong Buy, with a target consensus of HK$254.33, indicating a potential upside of 33.93%. Additionally, DBS also maintains a Buy rating with a price target of HK$290.00."
datetime: "2026-05-14T01:05:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286337391.md)
  - [en](https://longbridge.com/en/news/286337391.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286337391.md)
---

# Citic Securities Sticks to Its Buy Rating for BeOne Medicines Ltd (6160)

Citic Securities analyst maintained a Buy rating on BeOne Medicines Ltd on May 12 and set a price target of HK$234.00. The company’s shares closed yesterday at HK$189.90.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

BeOne Medicines Ltd has an analyst consensus of Strong Buy, with a price target consensus of HK$254.33, which is a 33.93% upside from current levels. In a report released on May 7, DBS also maintained a Buy rating on the stock with a HK$290.00 price target.

### Related Stocks

- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)
- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)
- [688235.CN](https://longbridge.com/en/quote/688235.CN.md)
- [06030.HK](https://longbridge.com/en/quote/06030.HK.md)
- [600030.CN](https://longbridge.com/en/quote/600030.CN.md)
- [D05.SG](https://longbridge.com/en/quote/D05.SG.md)
- [BGNE.US](https://longbridge.com/en/quote/BGNE.US.md)

## Related News & Research

- [BeOne Medicines Ltd (6160) Gets a Buy from CMBC International](https://longbridge.com/en/news/285886964.md)
- [Bank of China Sticks to Their Buy Rating for BeOne Medicines Ltd (6160)](https://longbridge.com/en/news/285667787.md)
- [Stifel Nicolaus Sticks to Their Buy Rating for Target Hospitality (TH)](https://longbridge.com/en/news/286494923.md)
- [BeOne Medicines Wins Conditional FDA Nod For Cancer Drug In Rare Blood Cancer](https://longbridge.com/en/news/286453582.md)
- [BeOne Medicines Highlights Global Footprint With Latest Form 10-Q Filing](https://longbridge.com/en/news/285368026.md)